Clinical Trial

A Study to Evaluate the Efficacy and Safety of HSK31858 Tablets in Patients with Bronchial Asthma

Enrolling by Invitation Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated December 24, 2024 (before its estimated March 22, 2026 completion). Its status may not reflect the trial's current state.
Summary
This is a phase II, randomised, double-blind, placebo-controlled, multicenter study to assess the efficacy and safety of HSK31858 in patients with bronchial asthma
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-10-09; most recent amendment 2024-12-19.
Status change: Not Yet Recruiting → Enrolling by Invitation 2024-12-19
Trial Details
NCT Number NCT06637254
Lead Sponsor Haisco Pharmaceutical Group Co., Ltd.
Conditions Bronchial Asthma
Enrollment 219 participants
Start Date 2024-10-22
Primary Completion 2026-03-22 (estimated)
Study Completion 2026-09-20 (estimated)
Updated on ClinicalTrials.gov 2024-12-24